Cargando…
Temporal Profiles and Dose-Responsiveness of Side Effects with Escitalopram and Duloxetine in Treatment-Naïve Depressed Adults
Side effect profiles of antidepressants are relevant to treatment selection and adherence among patients with major depressive disorder (MDD), but several clinically-relevant characteristics of side effects are poorly understood. We aimed to compare the side effect profiles of escitalopram and dulox...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071033/ https://www.ncbi.nlm.nih.gov/pubmed/30018196 http://dx.doi.org/10.3390/bs8070064 |
_version_ | 1783343791463202816 |
---|---|
author | Polychroniou, Philip E. Mayberg, Helen S. Craighead, W. Edward Rakofsky, Jeffrey J. Aponte Rivera, Vivianne Haroon, Ebrahim Dunlop, Boadie W. |
author_facet | Polychroniou, Philip E. Mayberg, Helen S. Craighead, W. Edward Rakofsky, Jeffrey J. Aponte Rivera, Vivianne Haroon, Ebrahim Dunlop, Boadie W. |
author_sort | Polychroniou, Philip E. |
collection | PubMed |
description | Side effect profiles of antidepressants are relevant to treatment selection and adherence among patients with major depressive disorder (MDD), but several clinically-relevant characteristics of side effects are poorly understood. We aimed to compare the side effect profiles of escitalopram and duloxetine, including frequencies, time to onset, duration, dose responsiveness, and impact on treatment outcomes. Side effects occurring in 211 treatment-naïve patients with MDD randomized to 12 weeks of treatment with flexibly-dosed escitalopram (10–20 mg/day) or duloxetine (30–60 mg/day) as part of the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) study were evaluated. Escitalopram- and duloxetine-treated patients experienced a similar mean number of overall side effects and did not differ in terms of the specific side effects observed or their temporal profile. Experiencing any side effect during the first 2 weeks of treatment was associated with increased likelihood of trial completion (86.7% vs. 73.7%, p = 0.045). Duloxetine-treated patients who experienced dry mouth were significantly more likely to achieve remission than those who did not (73.7% vs. 44.8%, p = 0.026). Side effects that resolved prior to a dose increase were unlikely to recur after the increase, but only about 45% of intolerable side effects that required a dose reduction resolved within 30 days of the reduction. At the doses used in this study, escitalopram and duloxetine have similar side effect profiles. Understanding characteristics of side effects beyond simple frequency rates may help prescribers make more informed medication decisions and support conversations with patients to improve treatment adherence. |
format | Online Article Text |
id | pubmed-6071033 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-60710332018-08-09 Temporal Profiles and Dose-Responsiveness of Side Effects with Escitalopram and Duloxetine in Treatment-Naïve Depressed Adults Polychroniou, Philip E. Mayberg, Helen S. Craighead, W. Edward Rakofsky, Jeffrey J. Aponte Rivera, Vivianne Haroon, Ebrahim Dunlop, Boadie W. Behav Sci (Basel) Article Side effect profiles of antidepressants are relevant to treatment selection and adherence among patients with major depressive disorder (MDD), but several clinically-relevant characteristics of side effects are poorly understood. We aimed to compare the side effect profiles of escitalopram and duloxetine, including frequencies, time to onset, duration, dose responsiveness, and impact on treatment outcomes. Side effects occurring in 211 treatment-naïve patients with MDD randomized to 12 weeks of treatment with flexibly-dosed escitalopram (10–20 mg/day) or duloxetine (30–60 mg/day) as part of the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) study were evaluated. Escitalopram- and duloxetine-treated patients experienced a similar mean number of overall side effects and did not differ in terms of the specific side effects observed or their temporal profile. Experiencing any side effect during the first 2 weeks of treatment was associated with increased likelihood of trial completion (86.7% vs. 73.7%, p = 0.045). Duloxetine-treated patients who experienced dry mouth were significantly more likely to achieve remission than those who did not (73.7% vs. 44.8%, p = 0.026). Side effects that resolved prior to a dose increase were unlikely to recur after the increase, but only about 45% of intolerable side effects that required a dose reduction resolved within 30 days of the reduction. At the doses used in this study, escitalopram and duloxetine have similar side effect profiles. Understanding characteristics of side effects beyond simple frequency rates may help prescribers make more informed medication decisions and support conversations with patients to improve treatment adherence. MDPI 2018-07-17 /pmc/articles/PMC6071033/ /pubmed/30018196 http://dx.doi.org/10.3390/bs8070064 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Polychroniou, Philip E. Mayberg, Helen S. Craighead, W. Edward Rakofsky, Jeffrey J. Aponte Rivera, Vivianne Haroon, Ebrahim Dunlop, Boadie W. Temporal Profiles and Dose-Responsiveness of Side Effects with Escitalopram and Duloxetine in Treatment-Naïve Depressed Adults |
title | Temporal Profiles and Dose-Responsiveness of Side Effects with Escitalopram and Duloxetine in Treatment-Naïve Depressed Adults |
title_full | Temporal Profiles and Dose-Responsiveness of Side Effects with Escitalopram and Duloxetine in Treatment-Naïve Depressed Adults |
title_fullStr | Temporal Profiles and Dose-Responsiveness of Side Effects with Escitalopram and Duloxetine in Treatment-Naïve Depressed Adults |
title_full_unstemmed | Temporal Profiles and Dose-Responsiveness of Side Effects with Escitalopram and Duloxetine in Treatment-Naïve Depressed Adults |
title_short | Temporal Profiles and Dose-Responsiveness of Side Effects with Escitalopram and Duloxetine in Treatment-Naïve Depressed Adults |
title_sort | temporal profiles and dose-responsiveness of side effects with escitalopram and duloxetine in treatment-naïve depressed adults |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071033/ https://www.ncbi.nlm.nih.gov/pubmed/30018196 http://dx.doi.org/10.3390/bs8070064 |
work_keys_str_mv | AT polychroniouphilipe temporalprofilesanddoseresponsivenessofsideeffectswithescitalopramandduloxetineintreatmentnaivedepressedadults AT mayberghelens temporalprofilesanddoseresponsivenessofsideeffectswithescitalopramandduloxetineintreatmentnaivedepressedadults AT craigheadwedward temporalprofilesanddoseresponsivenessofsideeffectswithescitalopramandduloxetineintreatmentnaivedepressedadults AT rakofskyjeffreyj temporalprofilesanddoseresponsivenessofsideeffectswithescitalopramandduloxetineintreatmentnaivedepressedadults AT aponteriveravivianne temporalprofilesanddoseresponsivenessofsideeffectswithescitalopramandduloxetineintreatmentnaivedepressedadults AT haroonebrahim temporalprofilesanddoseresponsivenessofsideeffectswithescitalopramandduloxetineintreatmentnaivedepressedadults AT dunlopboadiew temporalprofilesanddoseresponsivenessofsideeffectswithescitalopramandduloxetineintreatmentnaivedepressedadults |